The forged prescription transformed Ruti Aga’s doping case from a two-year suspension into a six-year ban. The Athletics Integrity Unit said the Ethiopian marathoner tested positive for methylprednisolone after winning the Meishan Renshou Half Marathon in China on March 15. The final sanction assigns two years to the prohibited-substance violation and four additional years to tampering with the investigation.
That distinction matters. The case wasn’t limited to whether a prohibited drug was present; investigators also assessed the evidence Aga submitted to explain how she had obtained it. Once they rejected that explanation as forged, the consequences grew substantially. A document meant to support her account became the basis for a separate violation.
A prescription investigators rejected
In an April interview, Aga told investigators she’d received the medication in Ethiopia to treat knee pain. She submitted a prescription in May. The AIU and the Ethiopian Anti-Doping Authority then examined the clinic and the person who signed it, finding that the listed clinic wasn’t real and that the signer was a relative who wasn’t recognized as a physician by the country’s medical authority.
The family member told investigators they’d worked at the clinic and had used old clinic stationery to write the prescription. Officials concluded that the document was forged. That finding led to a separate anti-doping rule violation for tampering, turning a dispute about a medication into a broader case about the reliability of evidence presented during an investigation.
Methylprednisolone is prohibited during competition under World Anti-Doping Agency rules. That status is central to the original violation, while the prescription’s authenticity shaped the additional penalty. In doping proceedings, an athlete’s explanation can matter, but it also has to withstand scrutiny. Here, investigators rejected the document offered to support Aga’s account.
Aga had been provisionally suspended since September, when the allegations became public. The final penalty assigns two years to the prohibited-substance violation and four more to tampering. The split makes clear that the six-year term reflects two findings, not simply an extended penalty for the positive test.
A major loss for the marathon circuit
The sanction sidelines a runner ranked 11th in the world at the time of the positive test. Aga won the 2019 Tokyo Marathon and the two preceding editions of the Xiamen Marathon. Her record also includes six top-three finishes at World Marathon Majors and a personal best of 2:18:09.
Those results give the ban significance beyond one race result. Aga had established herself among the sport’s leading marathoners, and her absence removes an experienced competitor from the circuit for the duration of the sanction. The record is substantial. The case’s details, though, will also shape how her achievements are discussed.
“We have made significant progress against doping in marathon running over the past six to seven years, but much remains to be done,” AIU chief executive Brett Clothier said. He said investigations help uncover doping and expose false explanations, adding that the case showed attempts to cheat would be exposed.
What the case signals for future investigations
The case underscores how documentation can shape the outcome of a doping investigation. Aga’s explanation rested on a prescription investigators determined was fabricated, and that finding lengthened her ban by four years. This is more significant than it looks: the credibility of supporting evidence became a distinct issue with its own consequence.
Here’s the thing: anti-doping cases often depend on records that can be checked against institutions and professional credentials. A prescription may help explain a medication’s use, but its value depends on whether investigators can verify its source. (And this is the part most people overlook.) Paperwork isn’t just background in a case like this; it can become evidence in its own right.
If you’re working in this space, the practical lesson is plain: explanations need reliable documentation, and investigators may examine who created a record as closely as what it says. The available account doesn’t establish what Aga knew about the prescription’s status. It does establish that officials found the clinic and signer did not support the document’s authenticity.
And yet, one case can’t answer every question about enforcement across the sport. It does show how a positive test and a rejected explanation can produce separate findings, with consequences that compound. For Aga, the outcome is a six-year ban and a case that will remain tied to both her competitive record and the investigation that followed.
